Hypertension is a risk factor for a large number of vision-threatening eye disorders. In this study, we investigated for the first time the retinal neural structure of the hypertensive BPH/2J mouse (Schlager mouse) and compared it to its control counterpart, the normotensive BPN/3J strain. The BPH/2J mouse is a selectively inbred mouse strain that develops chronic hypertension due to elevated sympathetic nervous system activity. When compared to the BPN/3J strain, the hypertensive BPH/2J mice showed a complete loss of outer layers of the neural retina at 21 weeks of age, which was indicative of a severe vision-threatening disease potentially caused by hypertension. To elucidate whether the retinal neural phenotype in the BPH/2J strain was attributed to increased BP, we investigated the neural retina of both BPN/3J and BPH/2J mice at 4 weeks of age. Our preliminary results showed for the first time that the BPH/2J strain develops severe retinal neural damage at a young age. Our findings suggest that the retinal phenotype in the BPH/2J mouse is possibly due to elevated blood pressure and may be contributed by an early onset spontaneous mutation which is yet to be identified or a congenital defect occurring in this strain. Further characterization of the BPH/2J mouse strain is likely to i) elucidate gene defects underlying retinal disease; ii) understand mechanisms leading to neural retinal disease and iii) permit testing of molecules for translational research to interfere with the progression of retinal disease. The animal experiments were performed with the approval of the Royal Perth Hospital Animal Ethics Committee (R535/17-18) on June 1, 2017.
Introduction
High blood pressure (or hypertension) is a condition of the circulatory system affecting over 1.3 billion individuals and it poses a significant public health challenge worldwide (Mills et al., 2016 ). An increase in systemic blood pressure (BP) alters retinal blood flow through impaired autoregulation and hyper-perfusion has a profound effect on the structure and function of the eye (van Koeverden et al., 2018) . The retinal, choroidal, and optic nerve circulation can undergo a series of pathophysiological changes in response to raised BP, leading to a broad range of clinical symptoms referred to as hypertensive retinopathy, hypertensive choroidopathy and hypertensive optic neuropathy. Furthermore, elevated BP is an important risk factor for the development of diabetic retinopathy, glaucoma, age-related macular degeneration and retinal vein and artery occlusion (Wong and Mitchell, 2007; Fraser-Bell et al., 2017) .
In particular, hypertensive retinopathy (HR) is a progressive disease characterized by a spectrum of retinal vascular and neural alterations in people with elevated BP. The prevalence of HR increases with severity of BP elevation and is a predictor of cardiovascular outcomes (Grosso et al., 2005) .
In the retina, with increased blood pressure, the blood-retinal barrier is compromised, resulting in hemorrhages, lipid exudates also known as hard exudates, and subsequent ischemia of nerve-fiber layers (cotton-wool spots) (Grosso et al., 2005; Fraser-Bell et al., 2017) . In the setting of further elevation of high blood pressure, raised intracranial pressure and associated optic nerve ischemia can lead to optic disc swelling or hypertensive optic neuropathy (Wong and Mitchell, 2007) . Alterations in retinal blood flow in HR leads to inflammation (Klein et al., 2000) , endothelial dysfunction (Klein et al., 2000; Delles et al., 2004) and angiogenesis due to upregulation of well-known growth factors such as vascular endothelial growth factor (VEGF) and its receptor VEGF-R2 (Suzuma et al., 2001; Tsai et al., 2005) .
A recent conceptual advancement in HR is the recognition that it is also a disease of the neurovascular unit, with multiple, interdependent cell types contributing to the dysfunction of the retina, as demonstrated in angiotensin II-induced hypertensive double transgenic rats (Reichhart et al., 2016) . New therapeutic approaches should therefore adopt a more holistic view of how hypertension affects the retina and tailor appropriate treatments to more precisely define disease phenotypes with the prospect of achieving better clinical outcomes. However, to date a suitable mouse model of hypertensive retinopathy does not exist. Our study is the first to examine the BPH/2J genetic model of hypertension for its ocular phenotype. This strain was selectively bred in 1964 by the Jacksons Laboratory using a two-way selection process (https://www.jax.org/strain/003005). The BPH/2J strain exhibited elevated BP compared to the hypotensive (BPL/1J) and normotensive (BPN/3J) controls that were bred in parallel. Whilst originally bred to evaluate the genetics of hypertension, this strain is currently being studied in a wide range of areas (Jackson et al., 2018; Watson et al., 2019) .
Characterization of a true hypertensive mouse model for its ocular phenotype would provide an important pre-clinical resource for the study of HR found in patients. In this study, we tested the hypothesis that hypertension in the BPH/2J strain may lead to the progressive development of HR in the BPH/2J mouse.
Materials and Methods
Experiments were carried out on 4-, 6-, 13-, 17-, or 21-weekold BPN/3J and BPH/2J mice of both genders and maintained in specific pathogen-free conditions at the Animal Resources Centre, Perth, Western Australia. At 13 weeks of age, male and female mice were greater than 19 and 16 g respectively. During the full duration of the experiment, mice were maintained under a 12-hour light/dark cycle, with free access to a standard chow diet and acidified water at the Royal Perth Hospital Animal Holding Facility.
The animal experiments were performed with the approval of the Royal Perth Hospital Animal Ethics Committee (R535/17-18) on June 1, 2017 and in accordance with the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research.
Measurement of blood pressure
All animals undergoing BP analysis were acclimatized for a period of 7 days. The BP measurements were conducted at 6 (n = 5) and 13 weeks (n = 11) in BPN/3J mice and 6 (n = 5) and 13 weeks (n = 14) in BPH/2J mice. Time-course BP measurements were carried out only on BPH/2J (n = 14) mice at 17 and 21 weeks.
A non-invasive computer automated multi-channel BP analysis system (MC4000, Hatteras Instruments, Cary, NC, USA) was used for the rapid evaluation of BPs. The mouse was placed on a 37.7°C metal platform surface and restrained in a holder (3 cm wide, 3.3 cm high) with free access to the tail. The tail was threaded through the occlusion cuff (13 mm long, 9 mm diameter) and positioned in the "v-notch" sensory assembly and immobilized with adhesive tape. The sensory assembly was equipped with an optical path with a LED light source above and a photosensor below the tail. The blood pulse wave in the tail artery is detected as transformed into an optical pulse signal by measurement of light extinction. Pulse detection, cuff inflation and pressure evaluation were automated by the SC1000 Comm software (Hatteras Instruments). Each recording session consisted of 20 inflation and deflation cycles per set, of which the first five cycles were "acclimation" cycles and were not used in the analysis, whereas the following 15 cycles were used for obtaining systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP). Measurement cycles with movement artefacts were excluded. The SBP indicates the pressure of circulating blood due to the heart pumping blood through the circulatory system; DBP indicates the pressure during ventricular relaxation where the cardiac ventricles refill with blood and MAP indicates the average pressure in the arteries during one cardiac cycle. All measurements were made in the morning (9:00-11:30 a.m.).
Eye specimen collection, section preparation and histological analysis
At the experimental end-point of 4 weeks (BPN/3J, n = 3 and BPH/2J, n = 6) or 21 weeks (BPN/3J, n = 3 and BPH/2J, n = 4) of age, animals were euthanized by methoxyflurane inhalation followed by cervical dislocation. Eyes were enucleated, cleaned and collected into 10% buffered formalin for histology. Upon fixation for 24 hours at room temperature, eyes were placed in 70% ethanol overnight followed by wax embedding in sagittal orientation (optic nerve parallel to cassette surface). Tissue blocks were trimmed for excess paraffin and sections were cut at 5 μm thickness using a Leica semi-automated RM2245 microtome (Leica Biosystems, Sydney, Australia) and placed in a 33°C water bath. Sections were aligned and collected onto super-frost slides. Each slide contained six sections. All slides were air dried overnight followed by oven drying at 60°C for 3 hours. Sections were deparaffinized in two changes of xylene, rehydrated in one change of absolute alcohol and 95% alcohol followed by 70% alcohol. Slides were then placed under running water followed by staining the nuclei with Gill's hematoxylin (Sigma, Sydney, Australia) and placed again under running water. Acid alcohol at 1% was used for differentiation. Slides were then placed in bluing Scott's water and washed in mild warm water, then dipped in 95% ethanol followed by treatment with alcoholic eosin (Sigma). Rapid dehydration in a series of ethanol (95% and 100% ethanol) followed by clearing twice in xylene and finally mounted using dibutylphthalate polystyrene xylene (DPX) (Sigma). Hematoxylin & eosin-stained retinal sections were visualized and imaged using the inverted microscopic systems Nikon Eclipse Ti (Nikon, Tokyo, Japan) equipped with a digital camera (CoolSNAP HQ2, Photometrics, Tucson, AZ, USA) linked to a computer running image analysis software NIS-Elements Advanced Research (Nikon). Morphometric measurements were obtained for retinal layer thickness of the full neural retina and individual retinal layers from the mid retinal region (4 weeks: BPN/3J, n = 3 and BPH/2J, n = 3 and 21 weeks: BPN/3J, n = 3 and BPH/2J, n = 3).
Cell death detection using TUNEL assay
Tissue sections from 4-week-old BPH/2J (n = 3) were processed for the identification of apoptosis by terminal deoxy-nucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) according to the manufacturer's instructions (In Situ Cell Death Detection Kit, POD, Roche Applied Science, Bavaria, Germany). In brief, the sections were dewaxed, and rehydrated through a graded series of ethanol and rinsed in distilled water as stated above. Sections underwent antigen retrieval in ethylenediaminetetraacetic acid (EDTA) pH 8.5 (Sigma) followed by three washes in phosphate buffer saline (PBS). Positive controls were treated with 2370 U/mL of DNase I mixed in 50 mM Tris-HCl (pH 7.5), and 1mg/mL bovine serum albumin for 10 minutes at room temperature. All slides were incubated with 3% H 2 O 2 for 10 minutes before washes with PBS. Sections were incubated with 50 µL of TUNEL reaction mixture containing both terminal deoxynucleotidyl transferase (TdT) and label solution, while corresponding negative controls were incubated only with the label solution for 60 minutes at 37°C in a humidified chamber. Following washes with PBS, each section was incubated with 50 µL of Converter-POD for 30 minutes at 37°C in a humidified chamber. Slides were washed in PBS and 50 µL of 3, 3′-diaminobenzidine substrate was added to each section. DNase I treated sections were washed in PBS after 20 seconds, while all other sections were washed in PBS after 10 minutes. Slides were mounted using DPX (Sigma) followed by visualization and imaging as described above for histological analysis.
Statistical analysis
All cardiovascular data are expressed as mean ± SEM. Data were compared using a two-tailed Student's t-test or oneway analysis of variance test where applicable. All analysis and graphs were generated using GraphPad Prism 7 (Graph-Pad Software Inc., La Jolla, California, USA). The data were deemed significant when P < 0.05.
Results
Blood pressure measurements in BPN/3J and BPH/2J mice Our tail-cuff BP analysis showed that at 13 weeks of age SBP, DBP and MAP were greater in hypertensive BPH/2J mice when compared to the normotensive BPN/3J mice (P < 0.01; Figure 1 ). Figure 2 shows that even at 6 weeks of age, the SBP, DBP and MAP were significantly greater (P < 0.01) in the BPH/2J mice when compared to BPN/3J mice. In BPH/2J mice, BP was measured every 4 weeks starting at 13 weeks until 21 weeks of age. A mild increase in BP was noted at 17 weeks of age but by 21 weeks of age, DBP and MAP were similar to that of 13-week-old mice (Figure 3) .
Retinal neural architecture BPN/3J and BPH/2J mice
At 21 weeks of age, BPN/3J eyes showed the normal neural structure of the retina whereby all eight retinal layers were visible (Figure 4A and C) . In contrast, the BPH/2J strain showed an overall thinner neural structure (Figure 4B and  D) with only five retinal layers (Figure 4D) . The BPH/2J retina was devoid of outer plexiform, outer nuclear and photoreceptor layers (Figure 4D) . In comparison to BPN/3J (n = 11) mice, BPH/2J (n = 14) mice showed significantly higher systolic, diastolic and mean arterial pressure respectively. DBP: Diastolic blood pressure; MAP: mean arterial pressure; SBP: systolic blood pressure. Data are presented as mean ± SEM; *P < 0.01, vs. In comparison to BPN/3J (n = 5) mice, BPH/2J (n = 5) mice showed significantly higher systolic, diastolic and mean arterial pressure respectively. DBP: Diastolic blood pressure; MAP: mean arterial pressure; SBP: systolic blood pressure. Data are presented as mean ± SEM; *P < 0.01, vs. BPN/3J mice (Student's t-test). It was evident that at 4 weeks of age, the BPH/2J retina appeared thinner (Figure 5B and D) when compared to the normal retina of the BPN/3J (Figure 5A and C) . At 4 weeks of age, the BPH/2J retina showed the presence of significantly thinner outer plexiform and outer nuclear layers (Additional Figure 1A) when compared to the BPN/3J retina (Additional Figure 1B) . However, the rod and cone cells and cell bodies showed complete absence (Figure 5D) , similar to that of 21 week old BPH/2J mice (Figure 4D) .
Retinal layer thickness in BPN/3J and BPH/2J mice
Upon retinal layer thickness measurement, it was noted that the overall retina was significantly thicker in BPN/3J mice when compared to BPH/2J mice at 4 (Figure 6 ) and 21 weeks of age (Figure 6) . We then compared the thickness of each layer between 4 week old BPN/3J and BPH/2J mice. In this group, the outer plexiform layer (OPL; P = 0.03) and outer nuclear layer (ONL; P = 0.0001) was significantly thinner in the BPH/2J mice (Figure 7) . In 21-week-old BPN/3J and BPH/2J mice, the comparison of retinal layer thickness showed absence of the OPL and ONL in the BPH/2J mice (Figure 7) .
In BPH/2J mice (Figure 7B) , the inner nuclear layer in 4-week-old mice was significantly thinner compared to 21 week old BPH/2J mice (P = 0.02). Furthermore, 4-weekold BPH/2J mice showed limited presence of the OPL and ONL when compared to the BPH/2J mice at 21 weeks of age, where complete loss of OPL and ONL was evident. In both 4and 21-week-old BPH/2J mice, the photoreceptor layer was absent (Figure 7B) .
Apoptosis in retinal cells of young BPH/2J mice
A marker for apoptosis is TUNEL staining, which demonstrates nuclear DNA fragmentation in cells progressing towards cell death. It is a common phenomenon seen in retinal degeneration in both mice (Portera-Cailliau et al., 1994) and in humans (Li and Milam, 1995) . In 4-week-old BPH/2J mice, TUNEL-positive cells were occasionally noted only in the retinal ganglion cell layer (Figure 8 ).
Discussion
The BPH/2J mouse strain is a genetic model of hypertension (Marques et al., 2011) which was selectively bred to achieve elevated blood pressure alongside their normotensive (BPN/3J) control counterparts (Schlager, 1994) . Recent studies have shown that the hypertension in the BPH/2J strain is caused by enhanced activation of the sympathetic nervous system since ganglion blockade leads to a greater depressor response in BPH/2J mice compared with BPN/3J controls (Davern et al., 2009; Jackson et al., 2013) . The hypertensive BPH/2J mice have shown elevated SBP (~36 mmHg greater at 4-21 weeks of age) when compared to the normotensive BPN/3J strain (Schlager and Sides, 1997) . The present study confirms previous findings that the BPH/2J mice are hypertensive when compared to BPN/3J mice at an early age such as 6 weeks of age and the BPH/2J mice consistently maintained the hypertensive status until 21 weeks of age (Schlager and Sides, 1997; Jackson et al., 2016) . Although the time point 4 weeks was not investigated in this study due to technical feasibility of the tail-cuff BP method (Marques et al., 2011) , it is highly unlikely that the BPH/2J mice are normotensive at 4 weeks of age. It is likely that the BP surge seen in the BPH/2J mice at 6 weeks of age also existed at 4 weeks of age.
Hypertension is a potential risk factor for several ocular diseases such as hypertensive retinopathy, age-related macular degeneration and glaucoma and these conditions can lead to compromised retinal vascular and neural structure. Given the hypertensive phenotype in the BPH/2J mouse, we assessed the retinal neural structure anticipating observing lesions indicative of hypertension driven ocular disease. To our knowledge, this study is the first to evaluate the eye phenotype in the BPH/2J hypertensive mouse, a model that exhibits a BP surge as observed in humans with hypertension. At 21 weeks of age, the eyes of the BPH/2J mouse showed severe retinal neural damage compared to the control counterparts, BPN/3J. As previously reported in other mouse strains, severe retinal damage caused to the outer layers of the retina is responsible for vision impairment (Won et al., 2011; Chang, 2013) . Furthermore, the retinal neural phenotype seen in the BPH/2J mice at 21 weeks of age may represent the retinal phenotype seen in humans and mouse models of retinal disease (Chang et al., 2002; Veleri et al., 2015) . However, given the known hypertensive background of the BPH/2J strain, one possible notion was that the elevated BP pattern in these mice may lead to progressive neural damage of the retina and possibly blindness. Therefore, we then set out to establish whether severe retinal neural damage in the BPH/2J strain may be attributed to an increase in BP. To achieve this, we investigated the neural retina of 4-week-old BPN/3J and BPH/2J mice. Our findings showed that in young BPH/2J mice, the neural retina was completely lacking the photoreceptor layer and the OPL and ONL were minimally present. At this young age, BPH/2J mice could be hypertensive (Schlager and Sides, 1997) and this may have contributed to the retinal neural damage seen in the BPH/2J mice. The extensively altered retinal phenotype in the BPH/2J strain is highly unlikely to be caused primarily due to the elevation of BP and it is entirely possible that the neural damage of the retina in this model could be the outcome of a genetic mutation or congenital defect. However, it is plausible that the elevated BP levels may have exacerbated the process of retinal damage in these mice. Therefore, our study has identified for the first time, a hypertensive mouse model with end-stage retinal neural damage possibly caused by a genetic mutation or congenital defect where the retinal damage process may have worsened by the elevated BP.
Genome-wide association studies conducted between BPN/3J and BPH/2J mice have identified genes altered in the early and established phases of hypertension (Marques et al., 2011) . Of the identified genes, Atp2b1 (plasma membrane calcium-transporting ATPase 1) is of particular interest as ATP2B1 plays important roles in the regulation of blood pressure through alteration of calcium handling and vasoconstriction in vascular smooth muscle cells (Kobayashi et al., 2012) . It is shown that plasma membrane calcium-transporting ATPase (PMCA) isoforms could play a specific functional role in the development of the mammalian retina. In particular, plasma membrane calcium-transporting ATPase 1 which is predominantly expressed in photoreceptors, cone bipolar cells and possibly horizontal cells, is shown to be of importance for the maintenance of normal photoreceptor cell function and signaling (Krizaj et al., 2002) .
Numerous serious or disabling eye diseases such as age-related macular degeneration, retinitis pigmentosa and glaucoma in humans affect millions of individuals world-wide (Johnson et al., 1999) . Mouse models of abnormal ocular phenotypes provide powerful tools for i) the identification of potential genetic markers of ocular disease and ii) allow possible testing of therapeutic interventions. Studies conducted on mouse models with altered retinal phenotypes are important to understand the pathophysiology, as well as the etiology of similar human ocular diseases.
It is noteworthy that spontaneous mutations leading to severe retinal neural damage occur in a wide variety of murine strains (Won et al., 2011; Chang, 2013) . However, the observation of altered phenotypes in mice of different genetic backgrounds can provide means for the identification of interacting genes and molecular pathways involved in the pathophysiology of a broad range of ocular diseases. This could be essential for the discovery of potential therapeutic targets as interventions for retinal neural damage. Further investigations in the BPH/2J strain should be of priority to identify potential genetic mutations which may possibly be responsible for the very early (~4 weeks) retinal neural damage. This could lead to the discovery of genetic defects similar to that of human retinal neural damage (Won et al., 2011) . The availability of experimental animals with similar genetic defects to humans with retinal neural damage, such as in retinitis pigmentosa, will assist with the development of suitable therapeutic approaches.
Future investigations will enable the full characterization of the retinal phenotype of the BPH/2J strain which can then be used to test therapeutics which will promote the development of neural retinal layers. A promising future approach could be the transplantation of healthy retinal photoreceptors which will aid the restoration of appropriate connections with inner retinal neurons (Gouras et al., 1992; Kwan et al., 1999) . Retinal sections from BPN/3J and BPH/2J mice at 4 and 21 weeks were stained with hematoxylin and eosin. Quantitative measurement of total retinal thickness showed a significant decrease in BPH/2J mice compared to BPN/3J mice at 4 and 21 weeks of age. Data are presented as the mean ± SEM; * and **P ≤ 0.0001 (Student's t-test). n = 3 mice/group. Representative images of TUNEL staining in the retinal ganglion cell layer of BPH/2J mice (n = 3). Samples not treated with DNase I (A and C) were exposed to 3,3′-diaminobenzidine for 10 minutes while the DNase I treated (B and D) were exposed to substrate for 20 seconds. 
